Document Detail

Embryological background for fetal surgery.
MedLine Citation:
PMID:  11754144     Owner:  NLM     Status:  MEDLINE    
Congenital malformations are one of the main topics, which must be addressed in the 21st century. Fetal surgery is expected to become a routine procedure for malformed fetal patients in the near future. This paper presents some important aspects of the embryological background required for fetal surgery and shows normal human embryos between the 4th and the 8th week of development.
H W Park
Related Documents :
23815274 - Can a smaller than expected crown-rump length reliably predict the occurrence of subseq...
20572114 - The making of fetal surgery.
23461814 - First trimester papp-a mom values predictive for breech presentation at term of pregnancy.
23035884 - Prediction of preeclampsia: liver function tests during the first 20 gestational weeks.
22215864 - To meta-analyse or not to meta-analyse: abortion, birth and mental health.
10366704 - Microglia in the human fetal spinal cord--patterns of distribution, morphology and phen...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Yonsei medical journal     Volume:  42     ISSN:  0513-5796     ISO Abbreviation:  Yonsei Med. J.     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-12-25     Completed Date:  2002-01-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0414003     Medline TA:  Yonsei Med J     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  609-14     Citation Subset:  IM    
Department of Anatomy, Yonsei University College of Medicine, C.P.O. Box 8044, Seoul 120-752, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Congenital Abnormalities / surgery
Embryonic and Fetal Development*
Fetus / physiology*,  surgery*
Gestational Age
Pregnancy Trimester, First

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The development of fetal surgery.
Next Document:  In utero hematopoietic stem cell therapy.